London: A newly identified drug may be used to effectively treat some patients hospitalised with COVID-19 pneumonia, according to a study published in The Lancet Respiratory Medicine journal The team, including researchers from the University of Birmingham and the University of Oxford, UK, tested namilumab — an antibody already in late-stage trials to treat rheumatoid arthritis […]
